See more : Slinger Bag Inc. (SLBG) Income Statement Analysis – Financial Results
Complete financial analysis of Procter & Gamble Health Limited (PGHL.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Procter & Gamble Health Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Red 5 Limited (REDLF) Income Statement Analysis – Financial Results
- Comerica Incorporated (0I1P.L) Income Statement Analysis – Financial Results
- SIM Technology Group Limited (912000.TW) Income Statement Analysis – Financial Results
- WinVest Acquisition Corp. (WINVR) Income Statement Analysis – Financial Results
- ZTE Corporation (000063.SZ) Income Statement Analysis – Financial Results
Procter & Gamble Health Limited (PGHL.BO)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.pghealthindia.com
About Procter & Gamble Health Limited
Procter & Gamble Health Limited engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally. The company provides over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Cosome, Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. The company was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India BV.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11.51B | 12.30B | 11.14B | 9.91B | 9.03B | 8.18B | 6.98B | 9.93B | 9.38B | 8.63B | 7.94B | 6.86B | 5.54B | 5.09B | 4.73B | 3.89B | 3.15B |
| Cost of Revenue | 5.73B | 3.62B | 3.40B | 3.37B | 5.02B | 2.85B | 2.51B | 4.30B | 4.52B | 4.16B | 3.81B | 3.15B | 2.57B | 2.08B | 2.06B | 1.60B | 1.26B |
| Gross Profit | 5.78B | 8.68B | 7.75B | 6.54B | 4.02B | 5.33B | 4.47B | 5.62B | 4.85B | 4.46B | 4.13B | 3.71B | 2.96B | 3.01B | 2.67B | 2.29B | 1.88B |
| Gross Profit Ratio | 50.22% | 70.57% | 69.51% | 66.03% | 44.47% | 65.16% | 64.09% | 56.67% | 51.76% | 51.73% | 52.07% | 54.12% | 53.53% | 59.17% | 56.44% | 58.92% | 59.82% |
| Research & Development | 0.00 | 57.10M | 65.50M | 39.30M | 57.27M | 20.50M | 35.60M | 4.20M | 121.10M | 110.40M | 86.20M | 50.10M | 28.30M | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 359.80M | 404.60M | 0.00 | 256.10M | 271.80M | 409.50M | 291.00M | 311.50M | 323.20M | 267.30M | 244.20M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 1.09B | 874.10M | 0.00 | 993.30M | 801.40M | 680.90M | 728.50M | 634.20M | 587.90M | 447.40M | 461.00M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.00B | 2.23B | 1.45B | 1.28B | 1.92B | 1.25B | 1.07B | 1.09B | 1.02B | 945.70M | 911.10M | 714.70M | 705.20M | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 183.90M | 131.90M | 181.00M | -73.93M | 11.10M | -465.70M | -308.70M | -347.40M | 5.60M | 5.10M | 4.90M | -240.70M | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 3.00B | 5.72B | 5.33B | 4.29B | 2.05B | 4.05B | 3.18B | 4.30B | 3.86B | 4.00B | 3.45B | 2.74B | 2.07B | 2.05B | 1.71B | 1.38B | 884.70M |
| Cost & Expenses | 8.73B | 9.34B | 8.73B | 7.66B | 7.07B | 6.90B | 5.69B | 8.61B | 8.38B | 8.16B | 7.26B | 5.89B | 4.64B | 4.13B | 3.77B | 2.98B | 2.15B |
| Interest Income | 0.00 | 143.30M | 110.70M | 150.60M | 373.20M | 171.90M | 178.10M | 179.00M | 154.70M | 164.80M | 181.40M | 172.40M | 145.60M | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 7.20M | 7.70M | 4.20M | 8.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 200.00K | 700.00K | 300.00K | 100.00K | 100.00K |
| Depreciation & Amortization | 274.00M | 277.50M | 267.30M | 296.90M | 192.87M | 209.40M | 191.20M | 248.10M | 234.20M | 126.80M | 100.70M | 89.00M | 79.50M | 71.00M | 75.10M | 57.30M | 65.90M |
| EBITDA | 3.01B | 3.43B | 2.81B | 2.64B | 2.56B | 1.79B | 1.18B | 1.57B | 1.23B | 595.70M | 792.90M | 1.07B | 829.20M | 1.17B | 1.04B | 974.80M | 1.06B |
| EBITDA Ratio | 26.18% | 27.84% | 25.27% | 27.18% | 23.92% | 17.87% | 23.23% | 16.67% | 13.23% | 6.90% | 9.99% | 15.54% | 14.98% | 23.01% | 21.98% | 25.03% | 33.82% |
| Operating Income | 2.79B | 3.01B | 2.44B | 2.23B | 1.97B | 1.28B | 768.20M | 1.01B | 620.10M | 468.90M | 692.20M | 976.70M | 749.70M | 1.10B | 964.80M | 917.50M | 998.70M |
| Operating Income Ratio | 24.20% | 24.50% | 21.91% | 22.53% | 21.79% | 15.67% | 11.00% | 10.18% | 6.61% | 5.43% | 8.72% | 14.25% | 13.54% | 21.62% | 20.39% | 23.56% | 31.72% |
| Total Other Income/Expenses | -52.80M | 129.10M | 91.90M | 82.00M | 397.27M | 297.50M | -303.70M | -168.20M | -159.70M | 196.70M | 190.30M | 191.20M | 206.20M | -700.00K | -300.00K | -100.00K | -100.00K |
| Income Before Tax | 2.73B | 3.14B | 2.53B | 2.33B | 2.37B | 1.58B | 989.90M | 1.15B | 833.30M | 665.60M | 882.50M | 1.17B | 955.90M | 957.10M | 964.50M | 917.40M | 998.60M |
| Income Before Tax Ratio | 23.74% | 25.55% | 22.74% | 23.54% | 26.19% | 19.31% | 14.18% | 11.60% | 8.89% | 7.71% | 11.12% | 17.03% | 17.27% | 18.80% | 20.39% | 23.56% | 31.72% |
| Income Tax Expense | 723.40M | 847.30M | 608.50M | 564.80M | 671.80M | 562.40M | 378.80M | 360.50M | 297.70M | 233.40M | 323.70M | 383.90M | 319.10M | 325.30M | 309.70M | 287.30M | 310.40M |
| Net Income | 2.01B | 2.29B | 1.93B | 1.77B | 1.69B | 8.39B | 939.10M | 791.30M | 535.60M | 432.20M | 558.80M | 784.00M | 636.80M | 631.80M | 654.80M | 630.10M | 688.20M |
| Net Income Ratio | 17.46% | 18.66% | 17.28% | 17.84% | 18.75% | 102.51% | 13.45% | 7.97% | 5.71% | 5.01% | 7.04% | 11.43% | 11.50% | 12.41% | 13.84% | 16.18% | 21.86% |
| EPS | 121.07 | 138.24 | 115.98 | 106.51 | 102.04 | 505.27 | 56.60 | 47.70 | 32.30 | 26.00 | 33.70 | 47.20 | 38.40 | 38.10 | 39.00 | 37.40 | 40.80 |
| EPS Diluted | 121.07 | 138.24 | 115.98 | 106.51 | 102.04 | 505.27 | 56.60 | 47.70 | 32.30 | 26.00 | 33.70 | 47.20 | 38.40 | 38.10 | 39.00 | 37.40 | 40.80 |
| Weighted Avg Shares Out | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.77M | 16.86M | 16.86M |
| Weighted Avg Shares Out (Dil) | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.60M | 16.77M | 16.86M | 16.86M |
Source: https://incomestatements.info
Category: Stock Reports